Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial

Ian Judson, Jaap Verweij, Hans Gelderblom, Jörg T Hartmann, Patrick Schöffski, Jean-Yves Blay, J Martijn Kerst, Josef Sufliarsky, Jeremy Whelan, Peter Hohenberger, Anders Krarup-Hansen, Thierry Alcindor, Sandrine Marreaud, Saskia Litière, Catherine Hermans, Cyril Fisher, Pancras C W Hogendoorn, A Paolo dei Tos, Winette T A van der Graaf, European Organisation and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

513 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences